Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose

Lignende værker

• In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
  af: Sheppard, John D., et al.
  Udgivet: (2018)
• Correction to: In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
  af: Sheppard, John D., et al.
  Udgivet: (2019)
• Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
  af: Toyos, Melissa M.
  Udgivet: (2019)
• The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery
  af: Silverstein, Steven M, et al.
  Udgivet: (2014)
• The ocular distribution of (14)C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model
  af: Baklayan, George A, et al.
  Udgivet: (2014)